Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weightlessness | 9 | 2019 | 27 | 1.970 |
Why?
|
| Tissue Engineering | 4 | 2019 | 75 | 1.290 |
Why?
|
| Weightlessness Simulation | 4 | 2019 | 26 | 1.030 |
Why?
|
| Bone and Bones | 4 | 2019 | 114 | 0.900 |
Why?
|
| Osteoblasts | 2 | 2019 | 44 | 0.690 |
Why?
|
| Fetus | 1 | 2019 | 101 | 0.580 |
Why?
|
| Stem Cells | 1 | 2018 | 152 | 0.510 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 152 | 0.380 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 2019 | 6 | 0.300 |
Why?
|
| Adaptation, Biological | 1 | 2009 | 29 | 0.300 |
Why?
|
| Lymphocytes | 2 | 2016 | 124 | 0.290 |
Why?
|
| Organoids | 2 | 2019 | 37 | 0.280 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 247 | 0.270 |
Why?
|
| Cytoskeleton | 2 | 2019 | 114 | 0.270 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2016 | 183 | 0.260 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 131 | 0.260 |
Why?
|
| Bioreactors | 2 | 2018 | 30 | 0.240 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2006 | 44 | 0.240 |
Why?
|
| Animals, Newborn | 1 | 2006 | 352 | 0.230 |
Why?
|
| Models, Biological | 3 | 2016 | 712 | 0.220 |
Why?
|
| Nitric Oxide | 2 | 2016 | 386 | 0.220 |
Why?
|
| Shiitake Mushrooms | 2 | 2016 | 2 | 0.210 |
Why?
|
| Polysaccharides | 2 | 2016 | 72 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1070 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2019 | 2157 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2019 | 1621 | 0.190 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 25 | 0.180 |
Why?
|
| Cell Shape | 2 | 2019 | 42 | 0.180 |
Why?
|
| Asparagus Plant | 1 | 2021 | 1 | 0.180 |
Why?
|
| Astronauts | 1 | 2019 | 6 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2019 | 12 | 0.150 |
Why?
|
| Virus Activation | 1 | 2019 | 38 | 0.150 |
Why?
|
| Subcellular Fractions | 1 | 2019 | 77 | 0.150 |
Why?
|
| Osteogenesis | 1 | 2019 | 57 | 0.150 |
Why?
|
| Solubility | 1 | 2019 | 139 | 0.140 |
Why?
|
| Cartilage | 1 | 2018 | 16 | 0.140 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 269 | 0.140 |
Why?
|
| Brain | 1 | 2006 | 1472 | 0.140 |
Why?
|
| Plant Extracts | 1 | 2021 | 302 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 216 | 0.130 |
Why?
|
| Humans | 13 | 2021 | 43102 | 0.130 |
Why?
|
| Duodenum | 1 | 2016 | 15 | 0.130 |
Why?
|
| Hypotension | 1 | 2016 | 24 | 0.120 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2016 | 31 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2016 | 51 | 0.120 |
Why?
|
| Protein Binding | 1 | 2019 | 1082 | 0.110 |
Why?
|
| Animals | 8 | 2021 | 16992 | 0.110 |
Why?
|
| Space Flight | 3 | 2019 | 17 | 0.110 |
Why?
|
| Aerospace Medicine | 1 | 2014 | 3 | 0.110 |
Why?
|
| Medicine, Ayurvedic | 1 | 2014 | 10 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 72 | 0.100 |
Why?
|
| Taste | 1 | 2014 | 45 | 0.100 |
Why?
|
| Bone Development | 1 | 2013 | 28 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 36 | 0.100 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 80 | 0.100 |
Why?
|
| Osteoclasts | 1 | 2013 | 28 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 1001 | 0.100 |
Why?
|
| Inflammation | 1 | 2016 | 758 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2014 | 469 | 0.080 |
Why?
|
| Humidity | 1 | 2009 | 12 | 0.080 |
Why?
|
| Biological Products | 1 | 2011 | 91 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 125 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1455 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 313 | 0.070 |
Why?
|
| Melanoma, Experimental | 1 | 2006 | 13 | 0.060 |
Why?
|
| Lateral Ventricles | 1 | 2006 | 11 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 39 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2006 | 14 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 114 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2006 | 75 | 0.060 |
Why?
|
| Myelin Sheath | 1 | 2006 | 46 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 75 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 210 | 0.060 |
Why?
|
| Colorimetry | 1 | 2006 | 53 | 0.060 |
Why?
|
| Cell Survival | 1 | 2009 | 945 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 128 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1081 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 88 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 135 | 0.060 |
Why?
|
| Rats, Wistar | 1 | 2006 | 283 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 652 | 0.050 |
Why?
|
| Rats | 2 | 2016 | 3735 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 883 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 934 | 0.050 |
Why?
|
| Ionomycin | 1 | 2002 | 11 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 43 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1271 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2021 | 13 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2021 | 28 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2021 | 57 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2021 | 95 | 0.040 |
Why?
|
| Adult | 3 | 2016 | 13872 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1596 | 0.040 |
Why?
|
| Memory | 1 | 2021 | 174 | 0.040 |
Why?
|
| Extraterrestrial Environment | 1 | 2019 | 3 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 665 | 0.040 |
Why?
|
| Neuroglia | 1 | 2019 | 133 | 0.040 |
Why?
|
| Hippocampus | 1 | 2021 | 594 | 0.030 |
Why?
|
| Cognition | 1 | 2021 | 473 | 0.030 |
Why?
|
| Female | 3 | 2021 | 24698 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2019 | 403 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2016 | 22 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 78 | 0.030 |
Why?
|
| Actins | 1 | 2016 | 164 | 0.030 |
Why?
|
| Male | 2 | 2021 | 23409 | 0.030 |
Why?
|
| Sodium | 1 | 2016 | 102 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 238 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 140 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 239 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 6644 | 0.030 |
Why?
|
| Sodium Glutamate | 1 | 2014 | 5 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 780 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 45 | 0.020 |
Why?
|
| Rotation | 1 | 2013 | 28 | 0.020 |
Why?
|
| Calcium | 1 | 2016 | 491 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2013 | 109 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 145 | 0.020 |
Why?
|
| Eating | 1 | 2014 | 167 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 61 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 678 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1263 | 0.020 |
Why?
|
| Tegafur | 1 | 2011 | 3 | 0.020 |
Why?
|
| Uracil | 1 | 2011 | 9 | 0.020 |
Why?
|
| Cytarabine | 1 | 2011 | 10 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1766 | 0.020 |
Why?
|
| Virus Diseases | 1 | 2011 | 27 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2011 | 55 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2011 | 45 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 107 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 98 | 0.020 |
Why?
|
| China | 1 | 2011 | 229 | 0.020 |
Why?
|
| Japan | 1 | 2011 | 348 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 375 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 195 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 220 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 432 | 0.020 |
Why?
|
| Melanins | 1 | 2006 | 42 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 508 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2006 | 290 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 411 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1019 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1869 | 0.010 |
Why?
|
| United States | 1 | 2011 | 5205 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 1377 | 0.010 |
Why?
|